A Message from the Dean
Mission Iraq
Dealmakers
A 1L Odyssey, Part 2
Isabelle Johnston Bids Farewell
Gloria Watts, Beloved Registrar, Gets Big Send-Off
The Brief
Graduation / Reunion
The Board of Overseers
Faculty News & Publications
Philanthropy
Alumni Briefs
In Memoriam
 
News & Events:
Head of Common Cause Decries Big-Money Politics, Bad Medicare Bill
1

FEATURED STORIES
Keedy Cup Goes to Team of Rubin and Gomez
Students Get Up Close Look at Workings of Pa. Superior Court
Head of Common Cause Decries Big-Money Politics, Bad Medicare Bill
Former NCC President Counsels “We the People” To Follow Museum’s Lead and Develop Philadelphia
Wax Exhorts Blacks to Take Responsibility for Academic Success
LALSA Celebrates Work of Latinos at Fun-Filled La Gran Fiesta
Hands-On Human Rights Seminar Debuts
Federal Housing Act Focus of Sparer Symposium
71 Percent of 3Ls Exceed Pro Bono Requirement
Who’s Who of Public Service
EJF Raises More Than $30,000
Penn Law Receives Rare Honor from Burton Awards
Design Award Goes to Roberts Hall Architects
Law School Appoints Wallace New Registrar
Kolker Brings Global Outlook to LL.M. Program
New Exchange Program with Japanese Law School
Chellie Pingree, President and CEO of Common Cause
AS MAJORITY LEADER of the Maine Senate, Chellie Pingree watched senior citizens cross the border into Canada to buy prescription drugs for far less than they pay in the United States. On one such trip, the group saved $19,000.

A few years later, as Common Cause President and CEO, Pingree watched in horror as Congress passed a Medicare bill that prohibits the U.S. government from negotiating the best price.

And she’s steamed. On a visit to Penn Law in March, Pingree, using the battle over Medicare as a case study, railed against the pernicious influence of big money in politics, and how special interests continue to pervert democracy.

Speaking at an event sponsored by the Penn Law American Constitution Society, Pingree said the Medicare bill, which takes effect in 2006, will ultimately hurt the people it is supposed to benefit: senior citizens.

“We are paying the highest prices in the world because our government has been unwilling to negotiate for the best possible price,” said Pingree.

Pingree said pharmaceutical companies, which generate more than half the profits of all the Fortune 500 companies, worked feverishly to protect their investment. The industry spent $120 million to lobby Congress and state officials, and employed seven lobbyists per senator, she said.

And to make matters worse, she said, the pharmaceutical industry had friends in government. Medicare head John Scully, a former industry executive, sought a job with a lobbying firm for drug companies while deliberations over the bill were taking place.

But such conflicts of interest need not mar the political process, she said, pointing to Maine as an example of good government. Maine, where elections are publicly financed, was the first state to pass comprehensive campaign finance reform. While she led the Senate, the state also approved a prescription drug bill, Maine Rx Plus, that is expected to provide deep discounts to 275,000 uninsured residents.

 
Previous Page Next Page